The Role of Langhana and amapachana in rare autoimmune disease takayashu arteritis -a case study
DOI:
https://doi.org/10.52482/ayurline.v10i02.1048Keywords:
Keywords: Takayasu’s arteritis ,Panchatiktakwath, Rasapachak, TriphalaAbstract
Introduction -Takayasu’s arteritis is a chronic vasculitis of medium and large vessels. The most involved vessel are the Carotid Artery, Aorta and other major branches.
Background -A 31-year-old woman who presented with history of syncope and dizziness with thickened walls of carotid artery in Magnetic Resonance Imaging angiogram finding. 2 years back she had 3 episodes of sudden syncope and unconsciousness and visited KEM hospital Parel, Mumbai. Takayashu arteritis was diagnosed at KEM hospital and they started her Prednisolone 40 mg/day orally, Methotrexate 15 mg/week, Aspirin 75 mg/day, and folic acid 5 mg/week. After discharge a maintenance dose of Methotrexate 10 mg/week and 8 mg/day of Methylprednisolone along with Aspirin 75 mg/day, and folic acid 5 mg/week orally was continued .
Case Report : Patient visited D.Y. Patil Ayurvedic hospital one year before with complains of giddiness and myalgia. Her inflammatory markers ESR was 90 mm/hr and CRP was 30mg/L. At D.Y.Patil Ayurvedic Hospital after Rogi Roga pariksha I started add on Ayurvedic medicines Panchatiktakwathchurna 3 gms BD morning and evening , Maha Manjishthadighanavati 2 tds ,Triphalachurna 5 gm hs ,Rasapachakvati 2 tds. Every day 15 hours fasting was advised as pathya daily 45 min walking was advised.
Results- After 11 months she started showing symptomatic relief and also 50% reduction in her inflammatory marker ESR and CRP levels turn normal with Ayurvedic medicines.
Conclusion :The case study shows that Takayasu arteritis (TA) was managed with Langhanaand AamapachakaAyurvedic medication with satisfactory outcome.
References
1.Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002 Jul;55(7):481-6. [PMC free article] [PubMed]
2.Arnaud L, Haroche J, Mathian A, Gorochov G, Amoura Z. Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun Rev. 2011 Nov;11(1):61-7. [PubMed]
3.Mason JC. Surgical intervention and its role in Takayasu arteritis. Best Pract Res Clin Rheumatol. 2018 Feb;32(1):112-124. [PubMed]
4.Comarmond C, Biard L, Lambert M, Mekinian A, Ferfar Y, Kahn JE, Benhamou Y, Chiche L, Koskas F, Cluzel P, Hachulla E, Messas E, Resche-Rigon M, Cacoub P, Mirault T, Saadoun D., French Takayasu Network. Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 Patients. Circulation. 2017 Sep 19;136(12):1114-1122. [PubMed]
5.Shah B, Chhetri R. Malignant Ischemic Stroke in a Young Female: A Rare Primary Manifestation of Takayasu Arteritis. Case Rep Neurol Med. 2019;2019:7942825. [PMC free article] [PubMed]
6.Vargas-Hitos JA, Jiménez-Jáimez J, Molina Navarro E, Salmerón Ruiz A, López Milena G, Jiménez-Alonso J. Takayasu arteritis, malignant hypertension and severe left ventricular hypertrophy. Int J Rheum Dis. 2019 May;22(5):951-955. [PubMed]
7.Kwon OC, Oh JS, Park MC, Hong S, Lee CK, Yoo B, Kim YG. Statins reduce relapse rate in Takayasu arteritis. Int J Cardiol. 2019 Jul 15;287:111-115. [PubMed]
8.Chauhan R, Luthra A, Mahajan S. Takayasu Arteritis with Cerebral Hypoperfusion: An Unusual Case. J Neurosci Rural Pract. 2019 Jan-Mar;10(1):170-171. [PMC free article] [PubMed]
9.Pandey G, editor. Charaka Samhita of Agnivesha, Sutra Sthana C.Su.chap.18 shloka 44. Ver. 38-42. 1st ed. Varanasi: Chaukhamba Sanskrit Sansthana; 2006.
10.Pandey G, editor. Charaka Samhita of Agnivesha, Chikitsa Sthana .chap.30 shloka 291-292) Ver. 38-42. 1st ed. Varanasi: Chaukhamba Sanskrit Sansthana; 2006.
REFERENCES
1.Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002 Jul;55(7):481-6. [PMC free article] [PubMed]
2.Arnaud L, Haroche J, Mathian A, Gorochov G, Amoura Z. Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun Rev. 2011 Nov;11(1):61-7. [PubMed]
3.Mason JC. Surgical intervention and its role in Takayasu arteritis. Best Pract Res Clin Rheumatol. 2018 Feb;32(1):112-124. [PubMed]
4.Comarmond C, Biard L, Lambert M, Mekinian A, Ferfar Y, Kahn JE, Benhamou Y, Chiche L, Koskas F, Cluzel P, Hachulla E, Messas E, Resche-Rigon M, Cacoub P, Mirault T, Saadoun D., French Takayasu Network. Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 Patients. Circulation. 2017 Sep 19;136(12):1114-1122. [PubMed]
5.Shah B, Chhetri R. Malignant Ischemic Stroke in a Young Female: A Rare Primary Manifestation of Takayasu Arteritis. Case Rep Neurol Med. 2019;2019:7942825. [PMC free article] [PubMed]
6.Vargas-Hitos JA, Jiménez-Jáimez J, Molina Navarro E, Salmerón Ruiz A, López Milena G, Jiménez-Alonso J. Takayasu arteritis, malignant hypertension and severe left ventricular hypertrophy. Int J Rheum Dis. 2019 May;22(5):951-955. [PubMed]
7.Kwon OC, Oh JS, Park MC, Hong S, Lee CK, Yoo B, Kim YG. Statins reduce relapse rate in Takayasu arteritis. Int J Cardiol. 2019 Jul 15;287:111-115. [PubMed]
8.Chauhan R, Luthra A, Mahajan S. Takayasu Arteritis with Cerebral Hypoperfusion: An Unusual Case. J Neurosci Rural Pract. 2019 Jan-Mar;10(1):170-171. [PMC free article] [PubMed]
9.Pandey G, editor. Charaka Samhita of Agnivesha, Sutra Sthana C.Su.chap.18 shloka 44. Ver. 38-42. 1st ed. Varanasi: Chaukhamba Sanskrit Sansthana; 2006.
10.Pandey G, editor. Charaka Samhita of Agnivesha, Chikitsa Sthana .chap.30 shloka 291-292) Ver. 38-42. 1st ed. Varanasi: Chaukhamba Sanskrit Sansthana; 2006.
REFERENCES
1.Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002 Jul;55(7):481-6. [PMC free article] [PubMed]
2.Arnaud L, Haroche J, Mathian A, Gorochov G, Amoura Z. Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun Rev. 2011 Nov;11(1):61-7. [PubMed]
3.Mason JC. Surgical intervention and its role in Takayasu arteritis. Best Pract Res Clin Rheumatol. 2018 Feb;32(1):112-124. [PubMed]
4.Comarmond C, Biard L, Lambert M, Mekinian A, Ferfar Y, Kahn JE, Benhamou Y, Chiche L, Koskas F, Cluzel P, Hachulla E, Messas E, Resche-Rigon M, Cacoub P, Mirault T, Saadoun D., French Takayasu Network. Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 Patients. Circulation. 2017 Sep 19;136(12):1114-1122. [PubMed]
5.Shah B, Chhetri R. Malignant Ischemic Stroke in a Young Female: A Rare Primary Manifestation of Takayasu Arteritis. Case Rep Neurol Med. 2019;2019:7942825. [PMC free article] [PubMed]
6.Vargas-Hitos JA, Jiménez-Jáimez J, Molina Navarro E, Salmerón Ruiz A, López Milena G, Jiménez-Alonso J. Takayasu arteritis, malignant hypertension and severe left ventricular hypertrophy. Int J Rheum Dis. 2019 May;22(5):951-955. [PubMed]
7.Kwon OC, Oh JS, Park MC, Hong S, Lee CK, Yoo B, Kim YG. Statins reduce relapse rate in Takayasu arteritis. Int J Cardiol. 2019 Jul 15;287:111-115. [PubMed]
8.Chauhan R, Luthra A, Mahajan S. Takayasu Arteritis with Cerebral Hypoperfusion: An Unusual Case. J Neurosci Rural Pract. 2019 Jan-Mar;10(1):170-171. [PMC free article] [PubMed]
9.Pandey G, editor. Charaka Samhita of Agnivesha, Sutra Sthana C.Su.chap.18 shloka 44. Ver. 38-42. 1st ed. Varanasi: Chaukhamba Sanskrit Sansthana; 2006.
10.Pandey G, editor. Charaka Samhita of Agnivesha, Chikitsa Sthana .chap.30 shloka 291-292) Ver. 38-42. 1st ed. Varanasi: Chaukhamba Sanskrit Sansthana; 2006.
REFERENCES
1.Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002 Jul;55(7):481-6. [PMC free article] [PubMed]
2.Arnaud L, Haroche J, Mathian A, Gorochov G, Amoura Z. Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun Rev. 2011 Nov;11(1):61-7. [PubMed]
3.Mason JC. Surgical intervention and its role in Takayasu arteritis. Best Pract Res Clin Rheumatol. 2018 Feb;32(1):112-124. [PubMed]
4.Comarmond C, Biard L, Lambert M, Mekinian A, Ferfar Y, Kahn JE, Benhamou Y, Chiche L, Koskas F, Cluzel P, Hachulla E, Messas E, Resche-Rigon M, Cacoub P, Mirault T, Saadoun D., French Takayasu Network. Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 Patients. Circulation. 2017 Sep 19;136(12):1114-1122. [PubMed]
5.Shah B, Chhetri R. Malignant Ischemic Stroke in a Young Female: A Rare Primary Manifestation of Takayasu Arteritis. Case Rep Neurol Med. 2019;2019:7942825. [PMC free article] [PubMed]
6.Vargas-Hitos JA, Jiménez-Jáimez J, Molina Navarro E, Salmerón Ruiz A, López Milena G, Jiménez-Alonso J. Takayasu arteritis, malignant hypertension and severe left ventricular hypertrophy. Int J Rheum Dis. 2019 May;22(5):951-955. [PubMed]
7.Kwon OC, Oh JS, Park MC, Hong S, Lee CK, Yoo B, Kim YG. Statins reduce relapse rate in Takayasu arteritis. Int J Cardiol. 2019 Jul 15;287:111-115. [PubMed]
8.Chauhan R, Luthra A, Mahajan S. Takayasu Arteritis with Cerebral Hypoperfusion: An Unusual Case. J Neurosci Rural Pract. 2019 Jan-Mar;10(1):170-171. [PMC free article] [PubMed]
9.Pandey G, editor. Charaka Samhita of Agnivesha, Sutra Sthana C.Su.chap.18 shloka 44. Ver. 38-42. 1st ed. Varanasi: Chaukhamba Sanskrit Sansthana; 2006.
10.Pandey G, editor. Charaka Samhita of Agnivesha, Chikitsa Sthana .chap.30 shloka 291-292) Ver. 38-42. 1st ed. Varanasi: Chaukhamba Sanskrit Sansthana; 2006.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Ayurline: International Journal of Research in Indian Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.
I Â declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website http://www.ayurline.in and online filled (uploaded) form.
Please read following declaration cum Agreement Carefully.:
I declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein.
I (We) agree (on behalf of me and my co-authors) to the following:
1- I (we) hereby assign to the publisher of the journal. Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) the right to (Electronically and print) publish on website www.ayurline.in and distribute the said manuscript and to create a derivative print work from the said manuscript. The assignment shall be effective so long as the manuscript is available on online networks.
2- I (we) shall remain the owner of the copyright in said manuscript. I (we) may publish the manuscript in any other journal or medium but such publication must include the notice that the manuscript was first published by Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journals including reference to the corresponding issue.
3- I (we) agree to hold the publisher of the Journal, Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) harmless for any unauthorized use of the paper by the journal subscribers.
4- I (we) confirm that I (we) have obtained all the necessary all permissions to include in the paper items such as quotations, figures, and the results of government-sponsored research/private or individual publishers/owners.
5- I (we) enclose where necessary written permission of authors and publishers to use any copyright material (previously published figures and tables).
6- I (we) confirm that after the publication of my (our) manuscript in Ayurline: International Journal of Research in Indian Medicine (IJ-RIM), the publisher has the sole authority of the paper/Research Article. The publisher has the authority to use the content of the whole paper or part of it, in an edited book, or other mediums or withdraw (unpublish) the article without the permission of authors.
8- If I / We found victims of plagiarism, (e.g. text, images, videos etc.) I/ We sole responsible for such legal matters. I/We also declared that the Chief Editor/Publisher, Editorial Board of this Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journal does not have any responsibility for plagiarism. Publisher shall not become any party in any legal matter and if any case is filed in court against plagiarisms or any copyright-related issues all expenses/Penalties should be paid/borne by me/we (Authors). I shall be obliged to pay all the costs of the court case if any happened in future.
7 -I voluntarily agreed to pay the necessary non-refundable evaluation fees of the my article, which are not the publication Charges.
8 - All disputes subject to Kurla, Mumbai court jurisdiction. This Copyright Licensing Agreement comes into force the day of sending this completed electronic form.